Two dose version of Johnson & Johnson vaccine 94% effective against Covid-19, study finds
A two-dose version of Johnson & Johnson’s coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday — making a two-dose regimen of J&J’s Janssen vaccine comparable to
Read More
Recent Comments